Total Clinical Trial Management Announces the Launch of Total Diversity


September 28, 2021

September 28, 2021 – Total Clinical Trial Management (TCTM), a woman-owned full service CRO, has recently announced a new brand and new focus – TOTAL Diversity. TCTM led by CEO, Diana Foster, Ph.D. has a long-standing history of educating, recruiting, and enrolling diverse populations into clinical trials.

TOTAL Diversity’s core business will remain as a full-service CRO providing on-time, high quality clinical management services for our clients. The short-term goals of the company are to develop a series of new business divisions within TOTAL Diversity, which include a Training Institute, Institutional Review Board, recruitment and retention services, and an expanded site network, all with a specialized focus in diversity.

“When TCTM began providing diversity services several years ago, I never anticipated the level of demand we are currently facing from our partners in the industry. To scale to the level needed to meet that demand, we have quickly executed on a strong leadership team to rapidly advance change in the industry,” states Foster.

About TOTAL Diversity Clinical Trial Management

TOTAL Diversity Clinical Trial Management is a full-service Contract Research Organization with an integrated focus on support services highlighting diversity and inclusion in clinical trials. Service offerings directed at diversity include consulting, feasibility assessment for sites, training programs, patient recruitment and retention services and more. Our growing network of sites includes experienced diversity-oriented researchers as well as those who have access to diverse populations.

Diana L. Foster, Ph.D

CEO and Chief Diversity Officer for TOTAL Diversity Clinical Trial Management

Diana L. Foster, Ph.D., is the CEO and Chief Diversity Officer for TOTAL Diversity Clinical Trial Management, a full-service Diversity Organization whose mission is to enhance diversity and inclusion in clinical research trials. Foster has served as the Vice President of Diversity, Equity, and Inclusion for the Society of Clinical Research Sites (SCRS) since 2016. She also held a position as the Vice President of Strategy and Development for SCRS originating programs such as the Global Impact Partner Programs and many other industry supported initiatives.

Foster is a thought-leader and sought-after expert in diversity and clinical site best practices. She is the author of the Diversity Site Assessment Tool and has published numerous research papers on the topic. Over the past two decades, she has addressed audiences across the world, published multiple papers and articles, and written five authoritative industry books including Global Issues in Patient Recruitment and Retention.

Jerome Adams, M.D.

Chairman of the Board for TOTAL Diversity Clinical Trial Management

Dr. Adams also currently serves as Executive Director of Health Equity Initiatives at Purdue University. He formerly served as the 20th United States Surgeon General and as a member of the President’s COVID-19 task force, where he was at the forefront of America’s most pressing health challenges throughout the pandemic, including working with companies to increase diversity in vaccine trials.

As the Chairman of the Board for TOTAL Diversity, Dr. Adams provides his in-depth knowledge of patient perspectives and industry views on diversity to create sustainable solutions and best practices to establish more diverse representation in clinical trials.